Biotech · Private company · Palo Alto, CA, US
Loxagen Inc.
Track this companyFree. Adds Loxagen Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Testing the Lipoxygenase Inhibitor BPN - 27332 as acute phase stroke treatment in the SPAN networkFiscal year 2025 · $225.7KNIH RePORTER 7U01NS132332-04 · fetched Nov 12, 2026